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ABSTRACT 
Objective: To correlate the level of Dickkopf-1 (DKK-1) and its role in rheumatoid arthritis (RA) patients of elderly age group. 
Methods:  Serum samples were collected elderly RA patients fulfilling the inclusion criteria coming to Geriatric outdoor clinic between June 
2018 to September 2018. DKK-1 was detected by ELISA. Serum C-reactive protein (CRP) levels, erythrocyte sedimentation rates (ESR), 
rheumatoid factor (RF) titers, and anti-cyclic citrullinated peptide antibody were also measured in patients with RA.  
Results: Twenty one patients were enrolled in study period. The serum level of DKK-1 was significantly higher in patients with severe RA with 
high DAS score (p < 0.01); The serum DKK-1 level was correlated with T-score (r= -0.588; p = 0.005), Z-Score(r= -0.458, p = 0.037) and the larson 
score of radiologic change (r = +0.673, p = 0.001) in RA, however not correlated significantly with ESR, CRP.  
Conclusion: DKK-1 may serve as a biomarker of bone erosion and correlates with the disease activity in RA patients of elderly age group. 
Keyword: DKK 1, Rheumatoid arthritis, Geriatric, Osteoporosis. 
 
Article Info: Received 02 Dec 2018;     Review Completed 11 Jan 2019;     Accepted 15 Jan 2019;     Available online 15 Jan 2019 
Cite this article as: 
Singh A, Correlation of level of expression of Wnt Signaling Pathway Inhibitor Dickkopf-1 with disease activity in Elderly 
patients of Rheumatoid Arthritis: A cross sectional study, Journal of Drug Delivery and Therapeutics. 2019; 9(1):348-350       
DOI: http://dx.doi.org/10.22270/jddt.v9i1.2343                                                   
*Address for Correspondence:  
Anup Singh, Associate Professor & Head, Deptt. of Geriatric Medicine., Institute of Medical Sciences, BHU, Varanasi-221005 
 
 
INTRODUCTION 
Rheumatoid arthritis (RA) is commonest form of symmetric 
peripheral polyarthritis involving predominantly small joints 
of the hands and feet. It is an autoimmune disorder 
characterized by chronic inflammation of synovial joints, 
which leads to articular destruction and functional disability. 
Bone erosion which is hallmark of RA is due to imbalance 
between bone formation and resorption for which 
osteoclasts play a major role.1 Growth and differentiation of 
osteoblasts is controlled by Dickkopf-1 (DKK-1) of Wingless 
(Wnt) signaling pathway.2  Dickkopf-1 (DKK-1) is an 
endogenous, secreted inhibitory factor in the canonical Wnt 
signaling by binding the Wnt coreceptor LRP5/65.3DKK-1 
could increase the expression of the osteoclast 
differentiation factors by enhancing RANKL/RANK 
interaction4. Further, DKK1 also plays an important role in 
the promotion of synovial angiogenesis5. Data regarding role 
of DKK-1 in RA elderly patients in bone destruction and 
inflammation in RA and its correlations with disease activity 
and laboratory characteristics of RA patients, have not been 
thoroughly clarified.  
 
MATERIAL AND METHODS 
A cross sectional study was done between June 2018 to 
September 2018 in Department of Geriatric Medicine, Sir 
Sunderlal Hospital BHU, a tertiary centre in eastern Uttar 
Pradesh, India after taking approval from Institute’s ethical 
committee. Informed consent was taken from the patients. 
All RA patients of age >50 years diagnosed by 2010 
ACR/EULAR criteria.( American rheumatology criteria) were 
included in study. Exclusion criteria included patients of age 
less than 50 years, patients on treatment of disease 
modifying anti rheumatic drug, evidence of steroid use in 
past 1 month, calcium supplement in last 3 months and 
presence of Diabetes Mellitus, or any chronic illness. No 
formal method of sample size calculation was made it being a 
pilot study.  
Clinical history and examination of all patients was done for 
the study. Routine investigations included complete blood 
counts, liver function test, random blood sugar, RA titre, CRP 
titre, anti-cyclic citrullinated peptide(anti CCP2) was 
obtained.  
X-ray of various joints of hand, wrist and feet was obtained 
and Larsen scoring was done for each.6 Bone marrow density 
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(BMD) was obtained for each sample.7 Disease Activity was 
measured by disease activity Score (DAS28) along with 
Modified Health assessment Questionnaire (MHAQ) score  
for all patients.8,9 
DKK1 measurement was done by RayBio® Human DKK-1 
ELISA Kit with intra-assay coefficient of variation percent 
(CV %), <10% and inter-assay CV %, <12%). 
Statistical Analysis: 
The data was analysed by software SPSS version 23.0. 
Continuous variables are presented as Mean+standard 
deviation (SD) and categorical variables are presented as 
numbers and/or percentages. Kolmogorov–Smirnov test was 
used to test the normality of distribution of continuous 
variables. The association between continuous variables was 
analysed by Pearson’s or Spearman’s correlation coefficients.  
RESULT 
Twenty one patients fulfilled the inclusion criteria in study 
period. Out of 21 cases, there were 15(71.4%) female and 6 
(28.57%) male patients. Mean age was 57.62+9.00 years. 
Comparison of various hematological and biochemical 
parameters of cases is shown in table 1. 
Mean DKK1 was 445.91 & DAS score was 2.19+0.87. Table 2 
show mean values of age, Larson score, Bone mineral 
density(BMD), DAS score, T and Z score, MHAQ score, CRP 
and ESR parameters and their correlation with DKK-1. 
DKK-1 level was correlated with T-score (r= -0.588; p = 
0.005), Z-Score(r= -0.458, p = 0.037), DAS28 score(r = 
+0.460, p = 0.036) and the larson score of radiologic change 
(r = +0.673, p = 0.001) in elderly RA patients, however it was 
not correlated significantly with ESR, CRP. 
Table 1: Hematological and biochemical parameters of 
patients 
Variable(N=21) Mean + S.D 
Age 57.62 +  9.00 
Hemoglobin (gm%) 10.37+ 2.02 
Total Leucocyte count(TLC) 10050.29 + 3160.35 
Platelet 2.79   +   2.60 
Creatinine 0.92   +   0.20 
Serum Calcium 8.71  + 0.93 
Urea 28.95 + 12.95 
 
Table 2: Correlation of Dickkopf-1 (Dkk-1) with different Parameters 
Variable (N=21) Mean+ SD Pearson correlation Coefficient value (r)  P-value 
Age 57.62 +  9.00 +0.508 0.019* 
Larsen Score 3.52   +  1.16 +0.673 0.001* 
BMD 
(Bone mineral density) 
0.88   +  0.28 -0.139 0.548 
T-Score -3.10 +   1.17 -0.588 0.005* 
Z-Score -2.20 +   0.95 -0.458 0.037* 
DAS Score 2.19   +  0.87 +0.460 0.036* 
MHAQ- Score 1.95   +  0.97 +0.397 0.074 
CRP 8.23  +    21.46 +0.210 0.360 
ESR 42.62  +  21.86 +0.181 0.432 
       Note:  
1. 0.1< I<rI <0.3 Small/Weak 
2. 0.3< I<rI <0.5 Medium/Moderate  
3. 0.5< I<rI  Large/Strong Correlation 
DISCUSSION 
Bone erosion and joint deformation is hallmark of 
inflammatory joint disease. DKK-1 has the strongest 
inhibitory effect on the Wnt pathway10. Previous studies 
have demonstrated that DKK-1 promote osteolytic lesions in 
vivo by enhancing osteoclastogenesis. Studies have shown 
that DKK1 is higher in healthy population with osteoporosis 
than non-osteoporosis. So it can be used as marker of 
osteoporosis. The infiltration of immunocompetent cells and 
proliferation of synovial fibroblasts in synovial lining leads 
to the formation of pannus tissue, which invades the 
articular cartilage and subchondral bone as a characteristic 
of RA. The above features were all associated with DKK-1. 11 
Mean haemoglobin level found to lower side in study group 
was 10.37+ 2.02 mg/dl. Previous studies have shown that 
anaemia develops in 30%-70% of patients with RA.12,13 From 
above results it’s concluded anaemia is common in patient 
with rheumatoid arthritis and usually anaemia of chronic 
disease was seen.  
Mean calcium level was found to have at lower level in study 
group was 8.71+0.93 mg/dl. It was in accoradnace with 
previous studies and suggest that rheumatoid arthritis 
patient have low calcium level with disease affecting the joint 
destruction and erosion, needs to supplement calcium along 
with other treatment options in RA.13 
In our study mean DKK1 level was found to be high in 
patients with osteoporosis as found in other studies. In our 
study, significantly correlated with T and Z Score.[14] Above 
results suggests that as rheumatoid arthrtis is chronic 
disease of bone having bone destructive effect so DKK1 in RA 
patient will be higher with osteoporosis than non 
osteoporosis. It suggest it can be used as a marker for bone 
destruction and follow up. 
DKK1 level shows positive correlation in RA patient with 
radiological progression. Larsen score for which was ; r value 
0.673 and p value of 0.001 ,which is statistically significant. 
In a study by Raphaèle Seror et al mean baseline DKK-1 level 
was higher among RA patients with radiological changes 
than without radiological progression (29.6 ± 13.3 vs 26.63 ± 
12.4 pmol/L) (p = 0.0084).14 
CONCLUSION 
Results suggest that with increase in disease progresions and 
bone distruction, serum level of DKK1 will increase. Hence 
serum DKK1 can used as marker for bone destruction and 
osteoporosis. 
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